Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001493152-19-004071
Filing Date
2019-03-28
Accepted
2019-03-28 08:01:43
Documents
78
Period of Report
2018-12-31

Document Format Files

Seq Description Document Type Size
1 form10-k.htm 10-K 1824026
2 ex31-1.htm EX-31.1 12005
3 ex31-2.htm EX-31.2 11946
4 ex32-1.htm EX-32.1 7592
5 ex32-2.htm EX-32.2 6317
  Complete submission text file 0001493152-19-004071.txt   5261450

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE cdxi-20181231.xml EX-101.INS 632793
7 XBRL SCHEMA FILE cdxi-20181231.xsd EX-101.SCH 56260
8 XBRL CALCULATION FILE cdxi-20181231_cal.xml EX-101.CAL 64451
9 XBRL DEFINITION FILE cdxi-20181231_def.xml EX-101.DEF 180201
10 XBRL LABEL FILE cdxi-20181231_lab.xml EX-101.LAB 403825
11 XBRL PRESENTATION FILE cdxi-20181231_pre.xml EX-101.PRE 307979
Mailing Address 2800 WOODLAWN DRIVE SUITE 129 HONOLULU HI 96822
Business Address 2800 WOODLAWN DRIVE SUITE 129 HONOLULU HI 96822 808-457-1400
CARDAX, INC. (Filer) CIK: 0001544238 (see all company filings)

EIN.: 454484428 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 333-181719 | Film No.: 19710005
SIC: 2834 Pharmaceutical Preparations